SynthesisBMC medicine2026
Early interventions for first onset of symptoms of mental health conditions: an umbrella review of systematic reviews.
Synthesis in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly intervention following mental health symptom onset has great potential in reducing the long-term burden on individuals, families and friends, and society. The main focus in service development and research has been on early intervention in psychosis, but advances have been made for some other mental health difficulties. We aimed to take stock of existing evidence regarding effectiveness, implementation and experiences of care for early intervention approaches through a systematic umbrella review.
methodsWe included systematic reviews of complex early intervention strategies including more than one component for early symptoms of mental health conditions with typical onset in young people under 25. We searched four databases (January 2019-May 2025) and synthesised results narratively. Quality was assessed using AMSTAR 2.
resultsTwenty-one reviews were included: eleven covering early intervention for psychosis already meeting diagnostic thresholds, four on early intervention for 'at risk' states for psychosis, three on eating disorders, one on bipolar disorder, and two on transdiagnostic approaches. Reviews of early intervention for psychosis suggest that intensive approaches can improve outcomes following first presentation to services, although the success of initiatives to reduce duration of untreated symptoms is less consistent. When most recently reviewed, interventions for those at high risk of psychosis appeared to have limited effectiveness in preventing transition, possibly because comparisons were often made with good-quality case management controls. We found little high-quality evidence regarding other diagnoses, although some early indications of success with eating disorders were reported. No reviews were found on early intervention for depression, anxiety, or 'personality disorders'. Stigma and lack of knowledge or support were barriers to rapid access, while insufficient service resources and staffing hindered effective delivery.
conclusionsDespite its great importance in reducing the global burden of mental ill-health, review evidence on early intervention following symptom onset remains limited, especially for conditions other than psychosis. For psychosis, some approaches now warrant attention to widespread implementation. Innovative approaches for eating disorders have emerged, but treatments supported by substantial and robust trials are urgently needed. Further evidence is also required for conditions including depression, anxiety, bipolar disorder, and 'personality disorder'.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.